In this issue:
– Urgency vs. triage prioritisation appropriateness of NZ dermatology referrals
– Adjuvant cemiplimab for high-risk cutaneous SCC
– Narrative vs. structured pathology reporting for cutaneous SCC
– Anti-PD-1 therapy in unresectable desmoplastic melanoma
– Characterisation of different clinical presentations of MCC
– Inherited mitochondrial genetics for predicting ICI efficacy in melanoma
– SPOTS: skin cancer prevention educational programme for adolescents
– Pembrolizumab-related toxicities in advanced melanoma
– Melanoma in pregnancy
Expert contributor
Dr Annie Wong is a NZ-trained medical oncologist currently based at Peter MacCallum Cancer Centre, Melbourne. Her oncological specialities include melanoma, lung cancer, and head and neck cancer. Her research interests include the management of melanoma brain metastases, mucosal melanoma and immunotherapy-related toxicities.
Expert contributor
Dr. Junie Wong is a Consultant Dermatologist and Mohs Micrographic Surgeon. She graduated from the University of Edinburgh Medical School and completed her postgraduate dermatology training in Liverpool, UK, before moving to New Zealand. She is a Fellow of the American College of Mohs Surgery, the Royal College of Physicians of Edinburgh, the Royal Australasian […]
Stay up to date with our latest clinical information.
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.